Select a category

Shares of Intuitive Surgical (ISRG) hit an all-time high Friday, a day after the medical device maker posted better-than-expected results on more use of its da Vinci minimally invasive surgical devices.

The company reported third-quarter adjusted earnings per share (EPS) of $1.84, with revenue advancing 17% year-over-year to $2.04 billion. Both exceeded consensus estimates of analysts polled by Visible Alpha.

The number of da Vinci procedures worldwide increased 18%, helping to drive instruments and accessories sales to $1.26 billion. Intuitive Surgical installed 379 da Vinci units in the quarter, 67 more than the same period a year ago, with 110 of those its new da Vinci 5.

Chief Executive Officer (CEO) Gary Guthart said the "core measures" of the company's business were healthy, and "we are pleased by customer adoption of da Vinci 5." 

Intuitive Surgical shares surged more than 8% to $512.74 after touching a record $517.61 soon after markets opened Friday. They are up more than 50% year-to-date.

Read more on Investopedia

CVS Health (CVS) stock tumbled about 7% in morning trading Friday after the pharmacy and healthcare giant announced the replacement of Chief Executive Officer (CEO) Karen Lynch with David Joyner, a longtime company veteran who most recently ran Caremark, its pharmacy benefit manager (PBM).

Joyner is taking the top job effective immediately, CVS said, as the company has weathered a difficult year of sales at its namesake pharmacies and problems with its bets on Medicare coverage that have led it to lower its full-year outlook several times already.

Newly appointed executive chairman Roger Farah said the board believes it was "the right time to make a change," and said Joyner's decades of experience with CVS "can help us more directly address the challenges our industry faces" and make necessary changes.

In addition to the CEO swap, CVS also provided preliminary guidance for third-quarter profit, projecting earnings per share (EPS) between 3 cents and 8 cents, and adjusted EPS of $1.05 to $1.10. Analysts are expecting EPS of $1.27, and adjusted EPS of $1.69, according to consensus estimates compiled by Visible Alpha.

The company is set to report third-quarter earnings Nov. 6, and said the lackluster projections are connected to costs related to its Medicare operations and other one-time expenses like store closures.

first reported the news that the CEO change was imminent, sending CVS stock lower Friday morning. After the announcement, shares were down more than 11% to $56.30, nearly 30% below where they started the year.

Read more on Investopedia

American Express (AXP) reported better net income than expected and lifted its full-year profit outlook in its third-quarter results Friday morning, following a string of strong reports from several of the country's biggest banks.

The credit card and financial services provider reported $16.64 billion in revenue, up from last year's $15.38 billion and just under the $16.67 billion consensus estimate of analysts compiled by Visible Alpha. Net interest income (NII) came in at $4.01 billion, up from $3.44 billion a year ago and above the $3.92 billion expectation.

Profit rose to $2.51 billion, or $3.49 per share, up from $2.45 billion and $3.30, respectively. Analysts had expected $2.38 billion and an identical $3.30-per-share result as last year. The company also lifted its full-year profit outlook, now projecting earnings per share (EPS) of $13.75 to $14.05, up from $13.30 to $13.80 previously.

Shares of American Express fell 4.4% soon after markets opened Friday to $273.31. They are up about 45% since the start of the year.

The report from American Express comes after a number of big banks posted better-than-expected earnings over the last week, but also increased their provisions for credit losses (PCLs), as data has shown Americans falling behind on debt like credit cards and car loans.

The card provider also lifted its PCL to $1.36 billion, just above the $1.34 billion analysts had expected.

UPDATE—This story has been updated with the latest stock price information.

Read more on Investopedia

The Actors Guild of Nigeria (AGN) has indefinitely suspended actress Halima Abubakar following accusations of defamation against her colleagues and prominent Nigerians.

In a statement posted on their official Instagram page, the AGN disclosed that a special investigative panel found Halima Abubakar guilty of making defamatory statements about her colleagues and patrons, as well as spreading false claims about extramarital affairs involving high-profile individuals.

As a result of the panel’s findings, the suspension takes immediate effect, barring Halima from participating in any AGN activities or film projects during this period.

Continue reading on Instablog

Procter & Gamble (PG) missed sales and net income estimates in its fiscal 2025 first-quarter earnings report Friday morning, but its adjusted profit beat expectations.

The company behind consumer products like Tide and Old Spice saw sales decline 1% year-over-year to $21.74 billion, below analysts' consensus estimates of $21.99 billion, according to Visible Alpha. P&G's net income came in at $3.99 billion, down from $4.56 billion a year ago and the $4.60 billion expectation.

P&G said it started a restructuring effort to its business in Argentina and Nigeria, and after accounting for the roughly $800 million in restructuring costs recorded in the quarter, P&G's adjusted profit of $4.76 billion came in just above estimates.

Chief Executive Officer (CEO) Jon Moeller said the company's results "keep us on track to deliver within our guidance ranges" for the full fiscal year.

Sales increased in P&G's Health Care and Fabric & Home Care units, but fell in the Beauty and Baby, Family & Feminine Care segments.

P&G shares were down less than 1% at $170.45 as markets opened Friday. They are up about 15% this year.

Read more on Investopedia

Tesla (TSLA) reports earnings Wednesday after the bell, weeks after its robotaxi-unveiling event left investors and analysts with a number of questions.

Analysts expect Tesla's quarterly revenue to rise to $25.41 billion from $23.35 billion the same time last year, according to Visible Alpha. The EV maker is also expected to report that profit fell slightly to $1.68 billion from $1.85 billion a year ago.

Analysts are somewhat split on Tesla stock, with the 19 analysts tracked by Visible Alpha holding nine "buy," seven "hold," and three "sell" ratings. Their average target price, $223.22, is just above Tesla's Thursday closing stock price of $220.89.

Tesla's third-quarter deliveries came in above estimates earlier this month but failed to spark a rally for the stock like last quarter's numbers did.

Wedbush Securities analysts said that, following the deliveries report, surpassing estimates was a "step in the right direction," but acknowledged that they and the broader market were hoping Tesla would beat projections by a wider margin.

However, Webdbush said after the delivery data and the robotaxi event that they retained their "outperform" rating and $300 price target—and "would be buyers on any weakness" in Tesla stock.

Tesla stock has moved less than 1% in each trading session this week after falling 8% last Friday, the day after the EV maker's robotaxi event. Tesla showcased the prototype "Cybercab," along with a larger capacity "Robovan" and projections from CEO Elon Musk on when Tesla's self-driving software could be approved, a step toward the autonomous taxis becoming legal to operate on the road.

Following the event, analysts said the lack of details about whether Tesla would plan to operate its fleet of robotaxis or sell them to customers, and the lack of an anticipated lower-cost Tesla model announcement, were among the factors driving the stock lower.

JPMorgan analysts, with an "underweight" rating and $130 price target, said the next day that the event was "notably lacking in detail," and said it affirmed their belief that Tesla stock's recovery from the lows it faced in the first half of the year was driven primarily by excitement for the recent robotaxi event rather than EV sales or earnings.

Read more on Investopedia